心血管风险评估工具对于代谢功能障碍相关的脂肪性肝病患者来说是不够的
A Sidney Barritt1, Elliot B Tapper2, Philip N Newsome3
1UNC Liver Center, University of North Carolina, Chapel Hill, North Carolina.
The American journal of gastroenterology
|June 11, 2025
概括
像FRS和PCE这样的心血管风险得分在患有MASLD的患者中表现不佳. 需要新的工具来准确评估这一群体的心血管事件风险.
科学领域:
- 心脏病学 心脏病学
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
背景情况:
- 心血管 (CV) 事件风险通常使用弗雷明汉风险评分 (FRS),聚合队列方程 (PCE) 和AHA PREVENT方程进行估计.
- 这些已建立的风险评估工具在患有代谢功能障碍相关性肝病 (MASLD) 的患者中的准确性仍然不确定.
研究的目的:
- 评估FRS,PCE和PREVENT在现实世界MASLD队列中的5-10年CV事件的预测准确度.
- 评估这些风险预测模型在MASLD群体中的校准和歧视.
主要方法:
- 从TARGET-NASH研究中对患有MASLD的美国成年人 (≥30岁) 的分析.
- 使用原始和重新校准的FRS和PCE以及原始PREVENT方程,估计心血管风险.
- 模型歧视 (C-统计) 和校准 (霍斯默-莱梅斯霍夫测试) 的评估.
主要成果:
- 弗雷明汉风险评分 (FRS) 显示预测能力较弱 (C统计值为0.58).
- AHA PREVENT模型也显示了有限的歧视 (C统计值为0.60).
- 无论是FRS还是PCE都表现出重大校准问题,高风险组的风险被高估,低风险组的风险被低估.
结论:
- 标准的心血管风险预测工具对于患有MASLD的患者来说是不够的.
- 需要改进风险评估策略,以应对MASLD患者心血管事件的高死亡率.
相关概念视频
Assessment of the Cardiovascular System II: Inspection
185
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
Head and Neck
185
Ultrasound II: Endoscopic Ultrasound and FibroScan
82
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
82
Overview of Lipid Metabolism
1.1K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.1K
Assessment of the Cardiovascular System I: Subjective Data
282
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
282
Liver Physiology
452
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
452
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3


